EUVIMEDEUVIMED entdecken
Crossref

Long-Term Outcomes of Definitive Chemoradiotherapy Plus Toripalimab for Locally Advanced Cervical Cancer: A Single-Center Phase II Trial with Integrated Pretreatment Transcriptomic Correlatives

Y.J. Cao, C. Li, S. Zhang, X. Sun, J.J. Chen, Z. Yuan

International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S98

DOI: 10.1016/j.ijrobp.2026.06.125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von Y.J. Cao und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Cao, Y., Li, C., Zhang, S., Sun, X., Chen, J., & Yuan, Z. (2026). Long-Term Outcomes of Definitive Chemoradiotherapy Plus Toripalimab for Locally Advanced Cervical Cancer: A Single-Center Phase II Trial with Integrated Pretreatment Transcriptomic Correlatives. International Journal of Radiation Oncology*Biology*Physics, 126(1), S98. https://doi.org/10.1016/j.ijrobp.2026.06.125

Vancouver

Cao Y, Li C, Zhang S, Sun X, Chen J, Yuan Z. Long-Term Outcomes of Definitive Chemoradiotherapy Plus Toripalimab for Locally Advanced Cervical Cancer: A Single-Center Phase II Trial with Integrated Pretreatment Transcriptomic Correlatives. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S98. doi:10.1016/j.ijrobp.2026.06.125

BibTeX
@article{Cao2026,
  author = {Cao, Y.J. and Li, C. and Zhang, S. and Sun, X. and Chen, J.J. and Yuan, Z.},
  title = {Long-Term Outcomes of Definitive Chemoradiotherapy Plus Toripalimab for Locally Advanced Cervical Cancer: A Single-Center Phase II Trial with Integrated Pretreatment Transcriptomic Correlatives},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {S98},
  doi = {10.1016/j.ijrobp.2026.06.125}
}
Kostenlos starten →